[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP2043740A2 - Transducteur à ultrasons pour un dispositif médical implanté à cavité métallique - Google Patents

Transducteur à ultrasons pour un dispositif médical implanté à cavité métallique

Info

Publication number
EP2043740A2
EP2043740A2 EP07813173A EP07813173A EP2043740A2 EP 2043740 A2 EP2043740 A2 EP 2043740A2 EP 07813173 A EP07813173 A EP 07813173A EP 07813173 A EP07813173 A EP 07813173A EP 2043740 A2 EP2043740 A2 EP 2043740A2
Authority
EP
European Patent Office
Prior art keywords
ultrasonic transducer
medical device
implantable medical
housing
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07813173A
Other languages
German (de)
English (en)
Inventor
Bin Mi
Abhijeet V. Chavan
Keith R. Maile
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardiac Pacemakers Inc
Original Assignee
Cardiac Pacemakers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiac Pacemakers Inc filed Critical Cardiac Pacemakers Inc
Publication of EP2043740A2 publication Critical patent/EP2043740A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A61N1/37252—Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • A61N1/37288—Communication to several implantable medical devices within one patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0026—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the transmission medium
    • A61B5/0028—Body tissue as transmission medium, i.e. transmission systems where the medium is the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile

Definitions

  • the present invention relates to transducers used in combination with an implantable medical device for wireless communication between the implantable medical device and remote devices implanted in the body.
  • the present invention more particularly relates to ultrasonic transducers used in combination with a metallic cavity implantable medical device.
  • Implantable medical devices are often used to treat a variety of medical conditions. Examples of implantable medical devices include drug delivery devices, pain management devices, and devices that treat heart arrhythmias.
  • One example of an implantable medical device used to treat heart arrhythmias is a cardiac pacemaker, which is commonly implanted in a patient to treat bradycardia (i.e., abnormally slow heart rate).
  • a pacemaker includes a pulse generator and leads, which form the electrical connection between the pulse generator and the heart.
  • An implantable cardioverter defibrillator (ICD) is used to treat tachycardia (i.e., abnormally rapid heart rate).
  • An ICD also includes a pulse generator and leads that deliver electrical energy to the heart.
  • Pulse generators typically include a metallic housing for a battery and electrical circuitry and a header for connecting the leads to the pulse generator.
  • Implantable medical devices are also useful in the treatment of heart failure.
  • cardiac resynchronization therapy (also commonly referred to as biventricular pacing) is an emerging treatment for heart failure, which involves stimulation of both the right and left ventricles to increase hemodynamic efficiency and cardiac output.
  • CTR cardiac resynchronization therapy
  • the treatment of heart failure and heart arrhythmias can be enhanced through the use of remote implanted devices.
  • One example of such a remote device is a pressure sensor located in the vasculature. Communication between the implantable medical device and the remote device can allow the sensor data to be downloaded by a clinician used to modify the therapy delivered by the implantable medical device, or both.
  • the present invention is an implantable medical device comprising a housing and an ultrasonic transducer having a communication frequency coupled to a portion of the housing.
  • the housing resonates at the communication frequency, and a casing is coupled to the housing and disposed over the ultrasonic transducer.
  • the casing is adapted to amplify the deformation of the ultrasonic transducer in a bending mode and transfer the bending moment to the housing.
  • the present invention is an implantable medical device comprising a housing having an upper portion and a lower portion.
  • a first ultrasonic transducer is coupled to a first connection rod and is coaxial with the first connection rod.
  • the first ultrasonic transducer and first connection rod are interposed between the upper and lower portions such that the first ultrasonic transducer is adapted to vibrate the upper and lower portions simultaneously.
  • the present invention is a method of optimizing an ultrasonic transducer and a housing of an implantable medical device. The method comprises determining system level requirements for the ultrasonic transducer and selecting an initial ultrasonic transducer based on the system level requirements.
  • a first finite element methods analysis is conducted to verify the feasibility of the initial ultrasonic transducer, and a second finite element methods analysis and water tank experiments are conducted to determine whether the housing and ultrasonic transducer have a desired vibration mode at a targeted ultrasonic communication frequency.
  • the ultrasonic transducer or the design of the housing are optimized based on the results of the first and second finite element methods analysis and water tank experiments.
  • the resonance frequency and amplitude of the optimized ultrasonic transducer are verified using finite element method analysis and water tank experiment.
  • a final ultrasonic transducer and housing design are selected based upon the results of the verifying step.
  • FIG. 1 is a combined cutaway and perspective view of an implantable medical device in accordance with one embodiment of the present invention.
  • FIG. 2 is a front view of the inside of the implantable medical device of FIG. 1 in accordance with one embodiment of the present invention.
  • FIGS. 3A-3B depict various views of the implantable medical device of FIG. 2.
  • FIGS. 4A-4B are various views of an implantable medical device in accordance with another embodiment of the present invention.
  • FIGS. 5A-5B are various views of an implantable medical device in accordance with yet another embodiment of the present invention.
  • FIG. 6 is a cross-sectional view of an implantable medical device in accordance with another embodiment of the present invention.
  • FIGS. 7A-7B are various views of an implantable medical device in accordance with another embodiment of the present invention.
  • FIG. 8 is a cross-sectional view of an implantable medical device in accordance with yet another embodiment of the present invention.
  • FIGS. 9A-9B are various views of an implantable medical device in accordance with another embodiment of the present invention.
  • FIGS. 10A-10B are various views of an implantable medical device in accordance with another embodiment of the present invention.
  • FIGS. 11A-11 B are various views of an implantable medical device in accordance with another embodiment of the present invention.
  • FIG. 12 is a cross-sectional view of an implantable medical device in accordance with yet another embodiment of the present invention.
  • FIG. 13 is a cross-sectional view of an implantable medical device in accordance with yet another embodiment of the present invention.
  • FIG. 14 is a flowchart depicting an exemplary method of optimizing an implantable medical device having an acoustic transducer in accordance with the present invention.
  • FIG. 1 is a perspective view of an implantable medical device (IMD) 10.
  • the IMD 10 includes a pulse generator 12 and a cardiac lead 14.
  • the lead 14 operates to convey electrical signals between the heart 16 and the pulse generator 12.
  • a proximal end 18 of the lead 14 is coupled to the pulse generator 12 and a distal end 20 is coupled to the heart 16.
  • the lead 14 includes a lead body 17 extending from the lead proximal end 18 to the lead distal end 20.
  • the heart 16 includes a right atrium 22, a right ventricle 24, and a pulmonary artery 26.
  • a tricuspid valve 28 is located between and controls the flow of blood from the right atrium 22 and the right ventricle 24.
  • a pulmonic valve 30 is located between and controls the flow of blood from the right ventricle 24 to the pulmonary artery 26.
  • the heart 16 also includes a left atrium 32, a left ventricle 34, and an aorta 36.
  • a mitral valve 38 is located between and controls the flow of blood from the left atrium 32 to the left ventricle 34.
  • An aortic valve 40 is located between and controls the flow of blood from the left ventricle 34 to the aorta 36.
  • the IMD 10 includes a plurality of leads 14.
  • it may include a first lead 14 adapted to convey electrical signals between the pulse generator 12 and the left ventricle 34 and a second lead 14 adapted to convey electrical signals between the pulse generator 12 and the right ventricle 24.
  • a helical electrode 42 penetrates the endocardium 43 of the right ventricle 24 and is embedded in the myocardium 44 of the heart 16.
  • the electrode 42 can be used to sense the electrical activity of the heart 16 or to apply a stimulating pulse to the right ventricle 24.
  • the cardiac lead 14 of the present invention can also be implanted in any other portion of the heart 16 as known in the art. For example, it may be implanted in the right atrium 22, the right ventricle 24, the pulmonary artery 26, the left ventricle 34, or in the coronary veins.
  • the IMD 10 includes multiple electrodes 42 disposed to sense electrical activity and/or deliver therapy to both the left and right sides of the heart 16.
  • the lead 14 can be an epicardial lead where the electrode 42 penetrates the epicardium 45.
  • a remote device 46 is located in the pulmonary artery 26.
  • the remote device 46 could be located in the right ventricle 24, the aorta 36, or any other location in or near the heart 16 or vasculature.
  • the remote device 46 shown in FIG. 1 comprises a pressure sensor.
  • the remote device 46 shown in FIG. 1 can be used to measure pressure in the pulmonary artery 26.
  • the remote device 46 measures end-diastolic pressure in the pulmonary artery 26.
  • the sensed pressure can be used to predict decompensation of a heart failure patient or to optimize pacing or defibrillation therapy.
  • a pressure sensor 46 adapted to measure pressure is disclosed in U.S. Patent No. 6,764,446 to Wolinsky et al.
  • the IMD 10 shown in FIG. 1 comprises a cardiac pacemaker
  • the IMD 10 could comprise any other medical device suitable for implantation in the body.
  • the IMD 10 could comprise a drug delivery device or a pain management device.
  • the remote device 46 can comprise any type of chronically implanted device or remote sensor adapted to deliver therapy or monitor biological functions.
  • the remote device 46 can be located anywhere in the body adapted for sensing a desired biological parameter or delivering therapy.
  • the remote device 46 could comprise a volume sensor or sense any other cardiac parameter, such as maximum or minimum pressure, or calculate a cardiac parameter derivative, such as the slope of the pressure.
  • the remote device 46 could comprise a glucose level monitor, a pulmonary sound sensor, a satellite pacing device, or any other remote sensing or therapy-delivering device.
  • a plurality of remote devices 46 could be implanted throughout the body and in wireless communication with each other and with an IMD 10.
  • FIG. 2 depicts a front view of the inside of the pulse generator 12.
  • the pulse generator 12 includes a housing 48 and a header 50.
  • An acoustic transducer 52 is attached to the inside of the housing 48 and is electrically connected to control circuitry (not shown).
  • the acoustic transducer 52 can be used as a sensor, an actuator, or as both a sensor and an actuator.
  • FIGS. 3A-3B depict cross-sectional views of the housing 48.
  • the acoustic transducer 52 includes electrodes 54 and can be coupled to the inside of the housing 48 by an insulating bonding layer 55.
  • the acoustic transducer 52 has a circular shape, but the acoustic transducer could take any other shape, such as rectangular, beam-shaped, circular, annular, or triangular.
  • the acoustic transducer 52 comprises a piezoelectric material. Piezoelectric materials adapted for use in the acoustic transducer 52 include piezo polymer, piezo crystal, or piezo ceramic materials. In one embodiment, the acoustic transducer 52 can comprise a polyvinylidine difluohde (PVDF) material. In another embodiment, the acoustic transducer 52 can comprise a lead zirconate titanate (PZT) material. In yet another embodiment, the acoustic transducer can comprise a piezo single crystal material, such as lead magnesium niobate - lead titanate (PMN-PT).
  • PVDF polyvinylidine difluohde
  • PZT lead zirconate titanate
  • the acoustic transducer can comprise a piezo single crystal material, such as lead magnesium niobate - lead titanate (PMN-PT).
  • the acoustic transducer 52 can comprise a cMUT transducer.
  • the thickness of the PZT material is approximately equivalent to the thickness of the housing 48.
  • the acoustic transducer 52 comprises PZT5A material, has a diameter of 25.4 millimeters or less, and has a thickness of 3 millimeters or less.
  • one electrode 54 is connected to an AC voltage source and the other electrode 54 is connected to ground.
  • the AC voltage can be applied to the acoustic transducer 52 to cause it to vibrate at a desired frequency.
  • both electrodes 54 could be driven simultaneously by an H-bhdge, as is known to one of skill in the art.
  • the acoustic transducer 52 has a mechanical resonance of greater than approximately 20 kiloHertz.
  • the acoustic transducer 52 has a mechanical resonance at a frequency of approximately 40 kiloHertz.
  • the acoustic transducer 52 can operate in an electrically resonant mode.
  • the acoustic transducer 52 is adapted to generate and receive acoustic waves having a frequency greater than approximately 20 kiloHertz, has a transmit sensitivity greater than approximately 100 Pascals per Volt at 0.25 meters of water or transmitting voltage response (TVR) greater than approximately 148 decibels (dB) referenced to (re) 1 microPascal per Volt at 1 meter of water, has a receive sensitivity greater than approximately 0.5 millivolt per Pascal or free-field voltage sensitivity (FFVS) greater than -186 dB re 1 Volt per microPascal, and has a total static capacitance less than or equal to approximately 20 nanoFarads.
  • TVR transmitting voltage response
  • FFVS free-field voltage sensitivity
  • the acoustic transducer 52 is adapted to generate and receive acoustic waves having a frequency of approximately 40 kiloHertz, has a transmit sensitivity greater than approximately 200 Pascals per Volt at 0.25 meters of water or TVR greater than approximately 154 decibels re 1 microPascal per Volt at 1 meter of water, has a receive sensitivity greater than approximately 0.5 millivolts per Pascal or FFVS greater than -186 dB re re 1 Volt per microPascal, and a total static capacitance less than or equal to approximately 8 nanoFarads.
  • the acoustic transducer 52 can be used for wireless communication between the IMD 10 and the remote device 46. As shown in FIG. 3B, acoustic signals are transmitted from the IMD 10 to the remote device 46 by applying an AC voltage or a charge change to the acoustic transducer 52 so that the acoustic transducer 52 deforms and the pulse generator housing 48 vibrates in response to the deformation. Acoustic signals sent from the remote device 46 are received by the acoustic transducer 52 when an impinging acoustic wave results in mechanical vibration of the housing 48, thus causing a voltage change or a charge density change in the acoustic transducer 52, which is detected by control circuitry (not shown).
  • FIGS. 4A-4B depict an embodiment of the present invention where a casing 62 encloses the acoustic transducer 52.
  • the casing 62 serves two functions. First, it bends when the acoustic transducer 52 deforms, thereby applying a bending moment to the housing 48. Second, it mechanically amplifies the deformation of the acoustic transducer 52, particularly when the housing 48 has a resonant mode at the desired frequency.
  • the casing 62 has a diameter of greater than 25 millimeters, a height of less than 4 millimeters, a top thickness of between 0.2 and 1 millimeter, and a wall thickness of between 3 to 6 millimeters.
  • the acoustic transducer 52 is attached to the casing 62 and there may be a gap or space between the acoustic transducer 52 and the housing 48. In another embodiment, the acoustic transducer 52 is attached to the housing 48 and there may be a gap between the acoustic transducer 52 and the casing 62.
  • FIGS. 5A-5B and 6 depict alternative embodiments of an IMD 10 having an acoustic transducer 52.
  • the housing 48 includes annular regions 64 having a thinner cross-section than a substantial portion of the housing 48.
  • the regions 64 shown in FIG. 5A comprise a "bull's eye” but alternatively could have any other shape, including a plurality of rectangles or circles.
  • the acoustic transducer 52 is adjacent to the regions 64, thereby allowing for increased vibration, movement, and/or deformation of the housing 48.
  • the thickness of the regions 64 is approximately 0.12 millimeter.
  • FIGS. 5A-5B and 6 depicts an alternative housing 48 where the region 64 takes the form of a corrugated or wavy region of the housing 48 located underneath the acoustic transducer 52.
  • the gaps 66 shown in FIGS. 5A-5B and 6 can contain air, nitrogen, some other gas, or vacuum.
  • FIGS. 5A-5B and 6 include the casing 62 described with respect to FIGS. 4A-4B, but in alternative embodiments, the casing 62 need not be present.
  • FIGS. 7A-7B depict an alternative embodiment of an IMD 10 having an acoustic transducer 52.
  • the acoustic transducer 52 has an annular shape.
  • the acoustic transducer 52 acts as a limiting structure and defines the resonance characteristics of the region 56 by establishing boundary conditions for the region 56.
  • the resonance characteristics of the region 56 enhance the performance of the acoustic transducer 52.
  • acoustic waves having the same frequency as the resonant frequency of the region 56 impact the region 56, the region 56 vibrates, resulting in deformation of the acoustic transducer 52. This deformation results in a voltage or a charge change in the acoustic transducer 52, which is detected by the control circuitry.
  • Driving the acoustic transducer 52 using an AC voltage or an H-bridge at the resonant frequency results in periodic deformation of the acoustic transducer 52. This deformation causes the region 56 to vibrate at the resonant frequency, thereby transmitting an acoustic wave from the region 56 at the desired frequency.
  • the dimensions of the acoustic transducer 52 can be determined using the following formula from Blevins, "Formulas for Natural Frequencies and Mode Shapes", ISBN 1-57524-184-6, herein incorporated by reference in its entirety:
  • a is the plate radius
  • h is the plate thickness
  • E Young's modulus
  • v Poisson's ratio
  • p is the density
  • ⁇ is the mass per unit area or p * h
  • ⁇ is a dimensionless frequency parameter dependent on the mode shape that can be found in Blevins.
  • the acoustic transducer 52 comprises a PZT material and defines a region 56 having a mechanical resonance of greater than approximately 20 kiloHertz.
  • the acoustic transducer 52 can be bonded to the housing 48 using epoxy or medical adhesive. Blevins provides additional mode resonant frequency formulas for additional shapes and boundary conditions.
  • the acoustic transducer 52 is mechanically bonded to a non-active limiting structure 58.
  • the limiting structure 58 has an annular shape and defines the resonant region 56.
  • Use of the non-active limiting structure 58 improves both the transmit and receive sensitivity of the acoustic transducer 52 when the resonant region 56 which has the same resonant frequency as the acoustic transducer 52.
  • the non-active limiting structure 58 transfers deformation between the acoustic transducer 52 and the housing 48.
  • FIGS. 9A-9B depict an alternative embodiment of the IMD 10. As shown in FIGS. 9A-9B depict an alternative embodiment of the IMD 10. As shown in FIGS. 9A-9B depict an alternative embodiment of the IMD 10. As shown in FIGS. 9A-9B depict an alternative embodiment of the IMD 10. As shown in FIGS. 9A-9B depict an alternative embodiment of the IMD 10. As shown in FIGS. 9A-9B depict an alternative embodiment of the IMD 10. As shown in
  • the limiting structure 58 is located in a corner 70 of the housing 48, has an approximately semicircular shape, and defines a resonant region 56.
  • the acoustic transducer 52 is bonded to the housing 48 and extends from the limiting structure 58 into the resonant region 56.
  • the length of the acoustic transducer 52 is determined by the strain/stress profile of the resonant region 56.
  • the deformation of the acoustic transducer 52 is constrained by the limiting structure 58 and the acoustic transducer 52 has a length of no more than half of the radius of the resonant region 56. As shown in the cross-sectional view of FIG.
  • the limiting structure 58 does not extend to the rear wall 72 of the housing, but in an alternative embodiment, the limiting structure 58 could extend to the rear wall 72. In yet another alternative embodiment, the limiting structure 58 could be located on the outside of the housing 48. In one embodiment, the limiting structure 58 could take the shape of an annular ring located on the outside of the housing 48.
  • the checkerboard pattern shown in FIG. 10A represents the mode shape of the housing 48 at approximately 40 kiloHertz.
  • the regions 73 represent regions of the housing 48 that are moving in the Z-axis.
  • These regions 73 can be moving either in a positive or negative direction along the Z-axis.
  • the dotted regions 73 can be moving in a positive direction along the Z-axis while the undotted regions can be moving in a negative direction along the Z-axis.
  • the lines 74 of the checkerboard pattern represent the nodal regions, or lines where the housing is motionless with respect to the Z-axis.
  • the corner 70 acts as a limiting structure and defines a resonant region 56, but in other embodiments, the transducer 52 could be located in a region 73 where the nodal lines 74 create a resonant region 56.
  • the acoustic transducer 52 is bonded to the top face 76 and is located in the resonant region 56. In one embodiment, the acoustic transducer 52 is located in a region of maximum stress and strain. In other embodiments, the shape of the housing 48 itself can be changed to obtain a desired frequency characteristic. In other embodiments, the housing 48 could be embossed or include a "dimple" to obtain a desired frequency characteristic.
  • FIGS. 11A-11 B show another alternative embodiment of the IMD 10 of the present invention.
  • the header 50 acts as a limiting structure on the acoustic transducer 52.
  • An aperture 78 is located in the header 50 and defines a resonant region 56.
  • the acoustic transducer 52 extends into the resonant region 56 and is bonded to the inside of the housing 48.
  • FIG. 12 shows a cross-sectional view of an alternative embodiment of the IMD 10 of the present invention.
  • the IMD 10 includes a housing 48 having an upper portion 48a and lower portion 48b.
  • a connection rod 84 is coupled to the upper portion 48a and a second connection rod 84 is coupled to the lower portion 48b.
  • An acoustic transducer 52 is interposed between the two connection rods 84.
  • the connection rods 84 have a bell shape in FIG. 12, but could have any other shape.
  • FIG. 13 shows a cross-sectional view of an alternative embodiment where an acoustic transducer 52 is coupled to each portion 48a, 48b and two connection rods 84 are interposed between the acoustic transducers 52.
  • the structure depicted in FIG. 13 also allows acoustic waves to propagate in two directions simultaneously.
  • the symmetrical design of FIG. 13 allows for easier design and manufacture of the acoustic transducers 52 and connection rods 84.
  • the embodiments shown in FIGS. 12 and 13 increase the sensitivity of the acoustic transducer or transducers 52.
  • the acoustic transducer or transducers 52 can comprise a piezoelectric material such as PZT or PVDF.
  • the portions 48a, 48b can apply a pre-stress to the acoustic transducer or transducers 52.
  • the acoustic transducer or transducers 52 and connection rods 84 are resonant in the thickness mode.
  • the acoustic transducer or transducers 52 and connection rods 84 are resonant in a radial mode.
  • the combined thickness of the connection rod 84 and the acoustic transducer 52 is approximately half of the wavelength of the communication frequency. In one embodiment, the combined thickness of the connection rod 84 and the acoustic transducer 52 is between 6 and 7 millimeters. In an alternative embodiment, a single connection rod 84 and a single acoustic transducer 52 are interposed between the portions 48a, 48b. In one embodiment, the single acoustic transducer 52 comprises a PZT material 1 centimeter in diameter and 1 millimeter thick.
  • connection rod 84 has a height of about 6 millimeters, a minimum diameter of 1 centimeter, a maximum diameter of 2.5 centimeters, and a taper beginning at a height of approximately 3 millimeters.
  • the thickness of the housing 48 is between 0.3 to 2 millimeters and the width of the housing 48 is between about 2.5 to 5 centimeters.
  • FIG. 14 depicts an exemplary method 200 for optimizing an acoustic transducer 52 and an IMD 10 for wireless communication with a remote device 46.
  • System level requirements such as the power budget, transducer sensitivity, mechanical size, material selection, and the vibration mode of the metallic housing 48 are determined (block 210).
  • An initial acoustic transducer 52 is selected based on the system level requirements (block 220).
  • a Finite Element Methods (FEM) analysis is performed to verify the feasibility of the initial transducer in simplified geometries (block 230). In this embodiment, verifying the feasibility includes determining whether the acoustic transducer 52 system level attributes fall within an acceptable range for the system level requirements.
  • FEM Finite Element Methods
  • FEM and water tank experiments are used to determine whether the metallic housing 48 and acoustic transducer 52 have the desired vibration mode at the targeted ultrasonic communication frequency (block 240).
  • the design can be optimized by varying the design of the housing 48, incorporating a casing 62, modifying the design 62 of the casing, modifying the characteristics of the acoustic transducer 52, including the dimensions, or any combination thereof (block 250).
  • the underwater resonance frequency and amplitude of the acoustic transducer 52 can be verified through Finite Element Method models and water tank experiments (block 260).
  • the experiments can be conducted in a water tank using a hydrophone and can utilize a scanning laser vibrometer (SLV).
  • SLV scanning laser vibrometer
  • One such SLV can be obtained from Polytec GmbH, Polytec-Platz 1 -7, D-76337 Waldbronn, Germany.
  • the design can again be optimized by varying the parameters such as housing 48 design, acoustic transducer 52 design, etc. (block 250). This optimization is repeated until the desired resonance characteristics are obtained and a final acoustic transducer design is reached (block 270).
  • the invention has been described with respect to implantable medical devices such as pacemakers and defibrillators, but could be adapted for use in any other implantable medical device, such as an insulin pump, neurostimulator, drug delivery system, pain management system, heart or lung sound sensor, or any other implantable medical device.
  • the remote device 46 can comprise any type of chronically implanted device or remote sensor adapted to deliver therapy or monitor biological functions, such as pressure sensor, glucose level monitor, a pulmonary sound sensor, volume sensor, satellite pacing device, or any other remote sensing or therapy-delivering device, and can be located anywhere in the body adapted for sensing a desired biological parameter or delivering therapy.
  • a plurality of remote devices 46 could be implanted throughout the body and in wireless communication with each other and with an IMD 10.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acoustics & Sound (AREA)
  • Pathology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Electrotherapy Devices (AREA)
  • Surgical Instruments (AREA)

Abstract

L'invention concerne un dispositif médical implantable comportant un boîtier et un transducteur à ultrasons dont une fréquence de communication est couplée à une partie du boîtier. Le boîtier résonne à la fréquence de communication et une enveloppe est couplée au boîtier et disposée sur le transducteur à ultrasons. L'enveloppe est conçue pour amplifier la déformation du transducteur à ultrasons dans un mode de courbure et transférer le moment de courbure au boîtier. L'invention concerne également un dispositif médical implantable comprenant un boîtier présentant une partie supérieure et une partie inférieure. Un premier transducteur à ultrasons est couplé à une première tige de connexion coaxialement à la première tige de connexion. Le premier transducteur à ultrasons et la première tige de connexion sont placés entre la partie supérieure et la partie inférieure de telle sorte que le premier transducteur à ultrasons fait vibrer simultanément la partie supérieure et la partie inférieure. L'invention concerne enfin un procédé d'optimisation d'un transducteur à ultrasons et un boîtier d'un dispositif médical implantable.
EP07813173A 2006-07-21 2007-07-20 Transducteur à ultrasons pour un dispositif médical implanté à cavité métallique Withdrawn EP2043740A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82005506P 2006-07-21 2006-07-21
PCT/US2007/073998 WO2008011577A2 (fr) 2006-07-21 2007-07-20 Transducteur à ultrasons pour un dispositif médical implanté à cavité métallique

Publications (1)

Publication Number Publication Date
EP2043740A2 true EP2043740A2 (fr) 2009-04-08

Family

ID=38776341

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07813173A Withdrawn EP2043740A2 (fr) 2006-07-21 2007-07-20 Transducteur à ultrasons pour un dispositif médical implanté à cavité métallique

Country Status (4)

Country Link
US (2) US7949396B2 (fr)
EP (1) EP2043740A2 (fr)
JP (1) JP2009544366A (fr)
WO (1) WO2008011577A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030036746A1 (en) 2001-08-16 2003-02-20 Avi Penner Devices for intrabody delivery of molecules and systems and methods utilizing same
ATE556648T1 (de) * 2004-11-24 2012-05-15 Remon Medical Technologies Ltd Implantierbares medizinprodukt mit integriertem akustischem wandler
US20060235349A1 (en) * 2005-04-14 2006-10-19 Brett Osborn Implantable anti-clogging device for maintenance of cerebrospinal fluid shunt patency
US7615012B2 (en) * 2005-08-26 2009-11-10 Cardiac Pacemakers, Inc. Broadband acoustic sensor for an implantable medical device
US7570998B2 (en) * 2005-08-26 2009-08-04 Cardiac Pacemakers, Inc. Acoustic communication transducer in implantable medical device header
EP2043740A2 (fr) 2006-07-21 2009-04-08 Cardiac Pacemakers, Inc. Transducteur à ultrasons pour un dispositif médical implanté à cavité métallique
US7912548B2 (en) * 2006-07-21 2011-03-22 Cardiac Pacemakers, Inc. Resonant structures for implantable devices
US8825161B1 (en) 2007-05-17 2014-09-02 Cardiac Pacemakers, Inc. Acoustic transducer for an implantable medical device
AU2008266678B2 (en) * 2007-06-14 2013-06-20 Cardiac Pacemakers, Inc. Multi-element acoustic recharging system
DE102008024857A1 (de) * 2008-05-23 2009-11-26 Biotronik Crm Patent Ag Drahtlose Durchführung für medizinische Implantate
US8626295B2 (en) * 2010-03-04 2014-01-07 Cardiac Pacemakers, Inc. Ultrasonic transducer for bi-directional wireless communication
CN105378957A (zh) * 2013-05-08 2016-03-02 达尔豪西大学 声波发射器和植入式接收器
US10888084B2 (en) 2015-07-15 2021-01-12 Nrg Systems, Inc. Ultrasonic bat deterrent system
EP3133745A1 (fr) * 2015-08-20 2017-02-22 Center for Integrated Smart Sensors Foundation Dispositif électronique et module d'antenne inclus dans celui-ci
CN108348158B (zh) 2015-11-03 2022-02-08 Nrg系统股份有限公司 用于野生动物阻吓的宽带超声换能器设备及其使用方法
IT201800002952A1 (it) * 2018-02-22 2019-08-22 St Microelectronics Srl Trasduttore ultrasonico microlavorato (mut) perfezionato, metodo di fabbricazione del mut, e metodo di progettazione del mut
WO2019199978A1 (fr) * 2018-04-10 2019-10-17 Nrg Systems, Inc. Techniques permettant de fournir une adaptation d'impédances acoustiques pour un dispositif transducteur ultrasonore à large bande et procédé de dissuasion de la faune sauvage utilisant celles-ci
US12059558B2 (en) * 2019-06-07 2024-08-13 Medtronic, Inc. Shield optimization for maximizing heat dissipation at the device tissue interface and improving fixation
AU2021273801A1 (en) 2020-05-19 2022-12-22 Coravie Medical, Inc. Injectable hemodynamic monitoring devices, systems and methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2239383C2 (ru) * 2002-12-30 2004-11-10 Государственное образовательное учреждение высшего профессионального образования "Алтайский государственный технический университет им. И.И.Ползунова" Ультразвуковая колебательная система для пластической хирургии

Family Cites Families (201)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2967957A (en) * 1957-09-17 1961-01-10 Massa Frank Electroacoustic transducer
DE1101331B (de) 1958-04-03 1961-03-09 Hoesch Ag Vorschub-, Biege- oder Leitwalze fuer Schraubennahtrohr-Schweissanlagen
DE1902849C3 (de) * 1968-01-25 1978-06-29 Pioneer Electronic Corp., Tokio Mechanisch-elektrisch bzw. elektrisch-mechanischer Wandler
US3568661A (en) * 1968-10-02 1971-03-09 Us Health Education & Welfare Frequency modulated ultrasound technique for measurement of fluid velocity
JPS4926890B1 (fr) * 1970-12-04 1974-07-12
US3676720A (en) * 1971-01-26 1972-07-11 Univ Ohio Method and apparatus for controlling frequency of piezoelectric transducers
US3757770A (en) * 1971-02-22 1973-09-11 Bio Tel Western Physiological pressure sensing and telemetry means employing a diode connected transistor transducer
JPS5221364B2 (fr) * 1971-11-04 1977-06-10
JPS5123439B2 (fr) * 1971-11-05 1976-07-16
JPS5410214B2 (fr) * 1973-10-15 1979-05-02
JPS5215972B2 (fr) * 1974-02-28 1977-05-06
JPS5220297Y2 (fr) * 1974-05-10 1977-05-10
US4170742A (en) 1974-07-15 1979-10-09 Pioneer Electronic Corporation Piezoelectric transducer with multiple electrode areas
GB1520118A (en) 1975-08-11 1978-08-02 Rank Organisation Ltd Transducers
US4051455A (en) * 1975-11-20 1977-09-27 Westinghouse Electric Corporation Double flexure disc electro-acoustic transducer
US4056742A (en) 1976-04-30 1977-11-01 Tibbetts Industries, Inc. Transducer having piezoelectric film arranged with alternating curvatures
US4127110A (en) 1976-05-24 1978-11-28 Huntington Institute Of Applied Medical Research Implantable pressure transducer
US4653508A (en) * 1976-06-21 1987-03-31 Cosman Eric R Pressure-balanced telemetric pressure sensing system and method therefore
US4593703A (en) * 1976-06-21 1986-06-10 Cosman Eric R Telemetric differential pressure sensor with the improvement of a conductive shorted loop tuning element and a resonant circuit
US4660568A (en) * 1976-06-21 1987-04-28 Cosman Eric R Telemetric differential pressure sensing system and method therefore
US4096756A (en) * 1977-07-05 1978-06-27 Rca Corporation Variable acoustic wave energy transfer-characteristic control device
US4181864A (en) * 1978-06-22 1980-01-01 Rca Corporation Matching network for switchable segmented ultrasonic transducers
US4227407A (en) 1978-11-30 1980-10-14 Cornell Research Foundation, Inc. Volume flow measurement system
US4481950A (en) 1979-04-27 1984-11-13 Medtronic, Inc. Acoustic signalling apparatus for implantable devices
FR2473242A1 (fr) 1980-01-08 1981-07-10 Thomson Csf Transducteur electroacoustique a dome actif
US4281484A (en) * 1980-02-11 1981-08-04 The Stoneleigh Trust System for precisely and economically adjusting the resonance frequence of electroacoustic transducers
DE3009068A1 (de) 1980-03-10 1981-09-24 Reinhard Dipl.-Ing. Lerch Piezopolymer-wandler mit fester membranunterstuetzung
FR2488814A1 (fr) * 1980-08-21 1982-02-26 Coatex Sa Agent de broyage pour suspension aqueuse de materiaux mineraux en vue d'applications pigmentaires
US4517665A (en) * 1980-11-24 1985-05-14 The United States Of America As Represented By The Department Of Health And Human Services Acoustically transparent hydrophone probe
US4433400A (en) * 1980-11-24 1984-02-21 The United States Of America As Represented By The Department Of Health And Human Services Acoustically transparent hydrophone probe
CA1157142A (fr) * 1981-01-09 1983-11-15 Robert G. Dunn Diaphragme pour senseur acoustique du type a flexion
JPS57177735A (en) 1981-04-27 1982-11-01 Toyoda Chuo Kenkyusho Kk Telemeter type brain nanometer
JPS58137317A (ja) * 1982-02-09 1983-08-15 Nec Corp 圧電薄膜複合振動子
DE3222349A1 (de) 1982-06-14 1984-01-05 Helga 6901 Gaiberg Berthold Elektronische uhr
US4577132A (en) 1983-07-05 1986-03-18 Toray Industries, Inc. Ultrasonic transducer employing piezoelectric polymeric material
US5438553A (en) 1983-08-22 1995-08-01 Raytheon Company Transducer
US4519401A (en) * 1983-09-20 1985-05-28 Case Western Reserve University Pressure telemetry implant
GB8325861D0 (en) * 1983-09-28 1983-11-02 Syrinx Presicion Instr Ltd Force transducer
US5178153A (en) 1984-03-08 1993-01-12 Einzig Robert E Fluid flow sensing apparatus for in vivo and industrial applications employing novel differential optical fiber pressure sensors
JPS60189307A (ja) * 1984-03-09 1985-09-26 Toshiba Corp 圧電薄膜共振器およびその製造方法
DE3409789A1 (de) * 1984-03-16 1985-09-26 Siemens AG, 1000 Berlin und 8000 München Piezoelektrischer luft-ultraschallwandler mit breitbandcharakteristik
JPS60216697A (ja) * 1984-04-12 1985-10-30 Matsushita Electric Ind Co Ltd 超音波セラミツクマイクロホン
GB8422876D0 (en) 1984-09-11 1984-10-17 Secr Defence Silicon implant devices
US4541431A (en) * 1984-09-20 1985-09-17 Telectronics Pty. Ltd. Use of telemetry coil to replace magnetically activated reed switch in implantable devices
US4653036A (en) * 1984-10-23 1987-03-24 The United States Of America As Represented By The Department Of Health And Human Services Transducer hydrophone with filled reservoir
US4580074A (en) * 1984-11-26 1986-04-01 General Motors Corporation Piezoelectric transducer with coded output signal
US4676255A (en) * 1985-07-03 1987-06-30 Cosman Eric R Telemetric in-vivo calibration method and apparatus using a negative pressure applicator
JPS6273900A (ja) * 1985-09-26 1987-04-04 Yokogawa Electric Corp 超音波送受波器
US4781715A (en) 1986-04-30 1988-11-01 Temple University Of The Commonwealth System Of Higher Education Cardiac prosthesis having integral blood pressure sensor
US4672976A (en) * 1986-06-10 1987-06-16 Cherne Industries, Inc. Heart sound sensor
US4835435A (en) * 1988-01-19 1989-05-30 Hewlett-Packard Company Simple, sensitive, frequency-tuned drop detector
US4911172A (en) 1988-03-28 1990-03-27 Telectronics Pacing Systems, Inc. Probe tip ultrasonic transducers and method of manufacture
US4846191A (en) 1988-05-27 1989-07-11 Data Sciences, Inc. Device for chronic measurement of internal body pressure
DE3824171A1 (de) * 1988-07-16 1990-01-18 Teroson Gmbh Masse-feder-systeme fuer schallschutzzwecke
US5024224A (en) * 1988-09-01 1991-06-18 Storz Instrument Company Method of readout of implanted hearing aid device and apparatus therefor
DE3831809A1 (de) * 1988-09-19 1990-03-22 Funke Hermann Zur mindestens teilweisen implantation im lebenden koerper bestimmtes geraet
US4940052A (en) 1989-01-25 1990-07-10 Siemens-Pacesetter, Inc. Microprocessor controlled rate-responsive pacemaker having automatic rate response threshold adjustment
US5012815A (en) * 1989-02-02 1991-05-07 Yale University Dynamic spectral phonocardiograph
US4958100A (en) 1989-02-22 1990-09-18 Massachusetts Institute Of Technology Actuated truss system
US4992692A (en) 1989-05-16 1991-02-12 Hewlett-Packard Company Annular array sensors
US5160870A (en) 1990-06-25 1992-11-03 Carson Paul L Ultrasonic image sensing array and method
AT397898B (de) 1991-09-25 1994-07-25 Akg Akustische Kino Geraete Membran für elektrodynamische wandler
US5304206A (en) * 1991-11-18 1994-04-19 Cyberonics, Inc. Activation techniques for implantable medical device
US5300875A (en) 1992-06-08 1994-04-05 Micron Technology, Inc. Passive (non-contact) recharging of secondary battery cell(s) powering RFID transponder tags
US5306294A (en) 1992-08-05 1994-04-26 Ultrasonic Sensing And Monitoring Systems, Inc. Stent construction of rolled configuration
US5367500A (en) 1992-09-30 1994-11-22 The United States Of America As Represented By The Secretary Of The Navy Transducer structure
US5628782A (en) 1992-12-11 1997-05-13 W. L. Gore & Associates, Inc. Method of making a prosthetic vascular graft
US5423334A (en) 1993-02-01 1995-06-13 C. R. Bard, Inc. Implantable medical device characterization system
US5410587A (en) 1993-03-01 1995-04-25 Matsushita Communication Industrial Corp. Of America Ultrasonic radiotelephone for an automobile
US5381067A (en) 1993-03-10 1995-01-10 Hewlett-Packard Company Electrical impedance normalization for an ultrasonic transducer array
US5314457A (en) * 1993-04-08 1994-05-24 Jeutter Dean C Regenerative electrical
US5339290A (en) 1993-04-16 1994-08-16 Hewlett-Packard Company Membrane hydrophone having inner and outer membranes
US5873835A (en) * 1993-04-29 1999-02-23 Scimed Life Systems, Inc. Intravascular pressure and flow sensor
US5381386A (en) 1993-05-19 1995-01-10 Hewlett-Packard Company Membrane hydrophone
US5289821A (en) 1993-06-30 1994-03-01 Swartz William M Method of ultrasonic Doppler monitoring of blood flow in a blood vessel
JPH0746694A (ja) * 1993-07-30 1995-02-14 Olympus Optical Co Ltd 超音波トランスデューサ
US5495137A (en) 1993-09-14 1996-02-27 The Whitaker Corporation Proximity sensor utilizing polymer piezoelectric film with protective metal layer
US5483501A (en) * 1993-09-14 1996-01-09 The Whitaker Corporation Short distance ultrasonic distance meter
US5476488A (en) 1993-12-15 1995-12-19 Pacesetter, Inc. Telemetry system power control for implantable medical devices
US5507786A (en) * 1994-04-14 1996-04-16 Pacesetter, Inc. System and method for measuring and storing parametric data pertaining to operating characteristics of an implantable medical device
US5488954A (en) 1994-09-09 1996-02-06 Georgia Tech Research Corp. Ultrasonic transducer and method for using same
EP0706835B1 (fr) 1994-10-10 1999-01-20 Endress + Hauser GmbH + Co. Méthode de mise en oeuvre d'un transducteur ultrasonique piezoélectrique et circuit destiné à sa mise en application
US5619476A (en) 1994-10-21 1997-04-08 The Board Of Trustees Of The Leland Stanford Jr. Univ. Electrostatic ultrasonic transducer
US5562714A (en) 1995-02-03 1996-10-08 Medtronic, Inc. Magnetic field strength regulator for implant
US5832924A (en) 1995-02-16 1998-11-10 Medwave, Inc. Method of positioning a sensor for determining blood pressure of an artery
US5554177A (en) * 1995-03-27 1996-09-10 Medtronic, Inc. Method and apparatus to optimize pacing based on intensity of acoustic signal
US5956292A (en) * 1995-04-13 1999-09-21 The Charles Stark Draper Laboratory, Inc. Monolithic micromachined piezoelectric acoustic transducer and transducer array and method of making same
US5571152A (en) 1995-05-26 1996-11-05 Light Sciences Limited Partnership Microminiature illuminator for administering photodynamic therapy
US5704352A (en) 1995-11-22 1998-01-06 Tremblay; Gerald F. Implantable passive bio-sensor
US5679026A (en) 1995-12-21 1997-10-21 Ventritex, Inc. Header adapter for an implantable cardiac stimulation device
WO1997030565A1 (fr) * 1996-02-15 1997-08-21 Neukermans Armand P Transducteurs biocompatibles ameliores
US5776178A (en) 1996-02-21 1998-07-07 Medtronic, Inc. Medical electrical lead with surface treatment for enhanced fixation
US5833603A (en) 1996-03-13 1998-11-10 Lipomatrix, Inc. Implantable biosensing transponder
US5825117A (en) 1996-03-26 1998-10-20 Hewlett-Packard Company Second harmonic imaging transducers
US6223081B1 (en) * 1996-03-28 2001-04-24 Medtronic, Inc. Implantable stimulus system having stimulus generator with pressure sensor and common lead for transmitting stimulus pulses to a body location and pressure signals from the body location to the stimulus generator
US5733313A (en) 1996-08-01 1998-03-31 Exonix Corporation RF coupled, implantable medical device with rechargeable back-up power source
US5879283A (en) * 1996-08-07 1999-03-09 St. Croix Medical, Inc. Implantable hearing system having multiple transducers
US5749909A (en) 1996-11-07 1998-05-12 Sulzer Intermedics Inc. Transcutaneous energy coupling using piezoelectric device
US5741316A (en) 1996-12-02 1998-04-21 Light Sciences Limited Partnership Electromagnetic coil configurations for power transmission through tissue
US5735887A (en) 1996-12-10 1998-04-07 Exonix Corporation Closed-loop, RF-coupled implanted medical device
US5792195A (en) * 1996-12-16 1998-08-11 Cardiac Pacemakers, Inc. Acceleration sensed safe upper rate envelope for calculating the hemodynamic upper rate limit for a rate adaptive cardiac rhythm management device
CA2247943C (fr) * 1997-01-03 2008-04-29 Biosense, Inc. Extenseur de detection de pression
US5957950A (en) 1997-01-21 1999-09-28 Northwestern University Medical School Vascular acoustic emission analysis in a balloon angioplasty system
JP3528491B2 (ja) * 1997-01-27 2004-05-17 松下電工株式会社 超音波送受波器
US7114502B2 (en) * 1997-02-26 2006-10-03 Alfred E. Mann Foundation For Scientific Research Battery-powered patient implantable device
DE69832713T2 (de) * 1997-02-26 2006-07-27 Alfred E. Mann Foundation For Scientific Research, Santa Clarita Batterie-betriebsgerät zur implantation in einem patienten
US7107103B2 (en) 1997-02-26 2006-09-12 Alfred E. Mann Foundation For Scientific Research Full-body charger for battery-powered patient implantable device
JPH10294995A (ja) * 1997-04-21 1998-11-04 Matsushita Electric Ind Co Ltd 防滴型超音波送信器
JP3831950B2 (ja) * 1997-05-02 2006-10-11 セイコーエプソン株式会社 通信装置、送信機、レーザ、生体用通信装置、反射光検出器および脈波検出装置
US5769881A (en) 1997-05-22 1998-06-23 Sulzer Intermedics Inc. Endocardial lead with multiple branches
EP0897690B1 (fr) 1997-08-15 2013-04-24 Academisch Ziekenhuis Leiden h.o.d.n. LUMC Capteur de pression utilisé dans un anéurisme
WO1999010874A1 (fr) 1997-08-23 1999-03-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Transducteur
US5807258A (en) 1997-10-14 1998-09-15 Cimochowski; George E. Ultrasonic sensors for monitoring the condition of a vascular graft
US5967986A (en) 1997-11-25 1999-10-19 Vascusense, Inc. Endoluminal implant with fluid flow sensing capability
US5843135A (en) 1997-10-20 1998-12-01 Medtronic, Inc. Pacing system with lead having a single conductor for connecting to pressure sensor and electrode
US6475170B1 (en) 1997-12-30 2002-11-05 Remon Medical Technologies Ltd Acoustic biosensor for monitoring physiological conditions in a body implantation site
US20030036746A1 (en) 2001-08-16 2003-02-20 Avi Penner Devices for intrabody delivery of molecules and systems and methods utilizing same
US6486588B2 (en) 1997-12-30 2002-11-26 Remon Medical Technologies Ltd Acoustic biosensor for monitoring physiological conditions in a body implantation site
US6140740A (en) 1997-12-30 2000-10-31 Remon Medical Technologies, Ltd. Piezoelectric transducer
US5935081A (en) * 1998-01-20 1999-08-10 Cardiac Pacemakers, Inc. Long term monitoring of acceleration signals for optimization of pacing therapy
JP3024750B2 (ja) * 1998-04-07 2000-03-21 日本電気株式会社 Ｄｓ−ｃｄｍａマルチユーザ干渉キャンセラ装置及びｄｓ−ｃｄｍａ通信システム
US6082367A (en) * 1998-04-29 2000-07-04 Medtronic, Inc. Audible sound communication from an implantable medical device
US6144880A (en) * 1998-05-08 2000-11-07 Cardiac Pacemakers, Inc. Cardiac pacing using adjustable atrio-ventricular delays
US6141588A (en) 1998-07-24 2000-10-31 Intermedics Inc. Cardiac simulation system having multiple stimulators for anti-arrhythmia therapy
US6044298A (en) * 1998-10-13 2000-03-28 Cardiac Pacemakers, Inc. Optimization of pacing parameters based on measurement of integrated acoustic noise
US6645145B1 (en) 1998-11-19 2003-11-11 Siemens Medical Solutions Usa, Inc. Diagnostic medical ultrasound systems and transducers utilizing micro-mechanical components
US6353762B1 (en) 1999-04-30 2002-03-05 Medtronic, Inc. Techniques for selective activation of neurons in the brain, spinal cord parenchyma or peripheral nerve
US6307302B1 (en) * 1999-07-23 2001-10-23 Measurement Specialities, Inc. Ultrasonic transducer having impedance matching layer
EP1143864B1 (fr) * 1999-08-05 2004-02-04 Broncus Technologies, Inc. Procedes et dispositifs permettant de creer des canaux collateraux dans les poumons
US7127290B2 (en) * 1999-10-01 2006-10-24 Cardiac Pacemakers, Inc. Cardiac rhythm management systems and methods predicting congestive heart failure status
US6554761B1 (en) * 1999-10-29 2003-04-29 Soundport Corporation Flextensional microphones for implantable hearing devices
US6629922B1 (en) 1999-10-29 2003-10-07 Soundport Corporation Flextensional output actuators for surgically implantable hearing aids
US6477406B1 (en) 1999-11-10 2002-11-05 Pacesetter, Inc. Extravascular hemodynamic acoustic sensor
US6527729B1 (en) * 1999-11-10 2003-03-04 Pacesetter, Inc. Method for monitoring patient using acoustic sensor
US6480733B1 (en) 1999-11-10 2002-11-12 Pacesetter, Inc. Method for monitoring heart failure
US6409675B1 (en) * 1999-11-10 2002-06-25 Pacesetter, Inc. Extravascular hemodynamic monitor
US6600949B1 (en) * 1999-11-10 2003-07-29 Pacesetter, Inc. Method for monitoring heart failure via respiratory patterns
US6328699B1 (en) 2000-01-11 2001-12-11 Cedars-Sinai Medical Center Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure
US6321428B1 (en) * 2000-03-28 2001-11-27 Measurement Specialties, Inc. Method of making a piezoelectric transducer having protuberances for transmitting acoustic energy
DE10015421C2 (de) * 2000-03-28 2002-07-04 Implex Ag Hearing Technology I Teil- oder vollimplantierbares Hörsystem
US6643548B1 (en) 2000-04-06 2003-11-04 Pacesetter, Inc. Implantable cardiac stimulation device for monitoring heart sounds to detect progression and regression of heart disease and method thereof
US6654638B1 (en) 2000-04-06 2003-11-25 Cardiac Pacemakers, Inc. Ultrasonically activated electrodes
DE10018334C1 (de) * 2000-04-13 2002-02-28 Implex Hear Tech Ag Mindestens teilimplantierbares System zur Rehabilitation einer Hörstörung
DE10018361C2 (de) * 2000-04-13 2002-10-10 Cochlear Ltd Mindestens teilimplantierbares Cochlea-Implantat-System zur Rehabilitation einer Hörstörung
US7335169B2 (en) * 2000-08-24 2008-02-26 Timi 3 Systems, Inc. Systems and methods for delivering ultrasound energy at an output power level that remains essentially constant despite variations in transducer impedance
US7220232B2 (en) * 2000-08-24 2007-05-22 Timi 3 Systems, Inc. Method for delivering ultrasonic energy
US6671550B2 (en) 2000-09-20 2003-12-30 Medtronic, Inc. System and method for determining location and tissue contact of an implantable medical device within a body
US6741714B2 (en) * 2000-10-04 2004-05-25 Widex A/S Hearing aid with adaptive matching of input transducers
US7273457B2 (en) 2000-10-16 2007-09-25 Remon Medical Technologies, Ltd. Barometric pressure correction based on remote sources of information
US7198603B2 (en) * 2003-04-14 2007-04-03 Remon Medical Technologies, Inc. Apparatus and methods using acoustic telemetry for intrabody communications
US6628989B1 (en) 2000-10-16 2003-09-30 Remon Medical Technologies, Ltd. Acoustic switch and apparatus and methods for using acoustic switches within a body
US7283874B2 (en) 2000-10-16 2007-10-16 Remon Medical Technologies Ltd. Acoustically powered implantable stimulating device
US6764446B2 (en) * 2000-10-16 2004-07-20 Remon Medical Technologies Ltd Implantable pressure sensors and methods for making and using them
US7024248B2 (en) * 2000-10-16 2006-04-04 Remon Medical Technologies Ltd Systems and methods for communicating with implantable devices
US6792308B2 (en) 2000-11-17 2004-09-14 Medtronic, Inc. Myocardial performance assessment
US6622044B2 (en) * 2001-01-04 2003-09-16 Cardiac Pacemakers Inc. System and method for removing narrowband noise
US7052466B2 (en) * 2001-04-11 2006-05-30 Cardiac Pacemakers, Inc. Apparatus and method for outputting heart sounds
JP4256683B2 (ja) * 2001-05-28 2009-04-22 エイチディー メディカル インコーポレイテッド 心臓診断システム
US6671544B2 (en) 2001-06-28 2003-12-30 Medtronic, Inc. Low impedance implantable extension for a neurological electrical stimulator
US6763722B2 (en) * 2001-07-13 2004-07-20 Transurgical, Inc. Ultrasonic transducers
JP2003079621A (ja) * 2001-09-14 2003-03-18 Toshiba Corp 超音波プローブおよび超音波診断装置
JP4007002B2 (ja) * 2001-10-26 2007-11-14 松下電工株式会社 超音波センサおよびその製造方法
JP2003218805A (ja) 2002-01-25 2003-07-31 Tama Tlo Kk 超音波を利用した電力および信号伝送装置
WO2003068047A2 (fr) * 2002-02-11 2003-08-21 Gold - T Tech, Inc. Methode pour prevenir la formation de thrombus
US7236821B2 (en) * 2002-02-19 2007-06-26 Cardiac Pacemakers, Inc. Chronically-implanted device for sensing and therapy
US8391989B2 (en) * 2002-12-18 2013-03-05 Cardiac Pacemakers, Inc. Advanced patient management for defining, identifying and using predetermined health-related events
US6740076B2 (en) * 2002-04-26 2004-05-25 Medtronic, Inc. Ultrasonic septum monitoring for implantable medical devices
US7228175B2 (en) * 2002-05-15 2007-06-05 Cardiac Pacemakers, Inc. Cardiac rhythm management systems and methods using acoustic contractility indicator
US7118531B2 (en) * 2002-09-24 2006-10-10 The Johns Hopkins University Ingestible medical payload carrying capsule with wireless communication
BE1015150A3 (nl) 2002-10-21 2004-10-05 Sonitron Nv Verbeterde transducent
US20040106954A1 (en) * 2002-11-15 2004-06-03 Whitehurst Todd K. Treatment of congestive heart failure
US7260429B2 (en) * 2002-12-02 2007-08-21 Cardiac Pacemakers, Inc. Method and apparatus for phonocardiographic image acquisition and presentation
US7123962B2 (en) * 2002-12-02 2006-10-17 Cardiac Pacemakers, Inc. Phonocardiographic image-based atrioventricular delay optimization
US7972275B2 (en) * 2002-12-30 2011-07-05 Cardiac Pacemakers, Inc. Method and apparatus for monitoring of diastolic hemodynamics
US7035684B2 (en) * 2003-02-26 2006-04-25 Medtronic, Inc. Method and apparatus for monitoring heart function in a subcutaneously implanted device
US6885889B2 (en) 2003-02-28 2005-04-26 Medtronic, Inc. Method and apparatus for optimizing cardiac resynchronization therapy based on left ventricular acceleration
EP1615692A2 (fr) 2003-04-11 2006-01-18 Cardiac Pacemakers, Inc. Discrimination de l'arythmie au moyen de parametres multiples
US8116868B2 (en) 2003-04-11 2012-02-14 Cardiac Pacemakers, Inc. Implantable device with cardiac event audio playback
US7015392B1 (en) * 2003-05-28 2006-03-21 Accellent, Inc. High torsional ductility wire and methods of making the same
US7006864B2 (en) 2003-06-17 2006-02-28 Ebr Systems, Inc. Methods and systems for vibrational treatment of cardiac arrhythmias
US7248923B2 (en) * 2003-11-06 2007-07-24 Cardiac Pacemakers, Inc. Dual-use sensor for rate responsive pacing and heart sound monitoring
US20050149138A1 (en) * 2003-12-24 2005-07-07 Xiaoyi Min System and method for determining optimal pacing sites based on myocardial activation times
US7115096B2 (en) * 2003-12-24 2006-10-03 Cardiac Pacemakers, Inc. Third heart sound activity index for heart failure monitoring
US7431699B2 (en) * 2003-12-24 2008-10-07 Cardiac Pacemakers, Inc. Method and apparatus for third heart sound detection
US7610092B2 (en) * 2004-12-21 2009-10-27 Ebr Systems, Inc. Leadless tissue stimulation systems and methods
US7765001B2 (en) * 2005-08-31 2010-07-27 Ebr Systems, Inc. Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices
US20060004290A1 (en) 2004-06-30 2006-01-05 Smith Lowell S Ultrasound transducer with additional sensors
US7489967B2 (en) 2004-07-09 2009-02-10 Cardiac Pacemakers, Inc. Method and apparatus of acoustic communication for implantable medical device
US7176602B2 (en) * 2004-10-18 2007-02-13 Ssi Technologies, Inc. Method and device for ensuring trandsducer bond line thickness
ATE556648T1 (de) 2004-11-24 2012-05-15 Remon Medical Technologies Ltd Implantierbares medizinprodukt mit integriertem akustischem wandler
US7522962B1 (en) 2004-12-03 2009-04-21 Remon Medical Technologies, Ltd Implantable medical device with integrated acoustic transducer
JP4583901B2 (ja) 2004-12-13 2010-11-17 富士フイルム株式会社 体腔内診断用超音波プローブ、および体腔内診断用超音波プローブの作製方法
US7570998B2 (en) * 2005-08-26 2009-08-04 Cardiac Pacemakers, Inc. Acoustic communication transducer in implantable medical device header
US7615012B2 (en) 2005-08-26 2009-11-10 Cardiac Pacemakers, Inc. Broadband acoustic sensor for an implantable medical device
US7616990B2 (en) 2005-10-24 2009-11-10 Cardiac Pacemakers, Inc. Implantable and rechargeable neural stimulator
US7917213B2 (en) 2005-11-04 2011-03-29 Kenergy, Inc. MRI compatible implanted electronic medical lead
JP5155311B2 (ja) 2006-07-21 2013-03-06 カーディアック ペースメイカーズ， インコーポレイテッド 植え込み型医療機器のヘッダ内に収容される超音波送受信トランスデューサ
EP2043740A2 (fr) 2006-07-21 2009-04-08 Cardiac Pacemakers, Inc. Transducteur à ultrasons pour un dispositif médical implanté à cavité métallique
US7912548B2 (en) * 2006-07-21 2011-03-22 Cardiac Pacemakers, Inc. Resonant structures for implantable devices
US10537730B2 (en) 2007-02-14 2020-01-21 Medtronic, Inc. Continuous conductive materials for electromagnetic shielding
AU2008266678B2 (en) 2007-06-14 2013-06-20 Cardiac Pacemakers, Inc. Multi-element acoustic recharging system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2239383C2 (ru) * 2002-12-30 2004-11-10 Государственное образовательное учреждение высшего профессионального образования "Алтайский государственный технический университет им. И.И.Ползунова" Ультразвуковая колебательная система для пластической хирургии

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2008011577A2 *

Also Published As

Publication number Publication date
US20080021509A1 (en) 2008-01-24
US20110190669A1 (en) 2011-08-04
US7949396B2 (en) 2011-05-24
JP2009544366A (ja) 2009-12-17
US8548592B2 (en) 2013-10-01
WO2008011577A3 (fr) 2008-05-29
WO2008011577A2 (fr) 2008-01-24

Similar Documents

Publication Publication Date Title
US7912548B2 (en) Resonant structures for implantable devices
US7949396B2 (en) Ultrasonic transducer for a metallic cavity implated medical device
US7570998B2 (en) Acoustic communication transducer in implantable medical device header
JP5155311B2 (ja) 植え込み型医療機器のヘッダ内に収容される超音波送受信トランスデューサ
EP2162185B1 (fr) Système de recharge acoustique à plusieurs éléments
US9095284B2 (en) Distance measurement using implantable acoustic transducers
US7522962B1 (en) Implantable medical device with integrated acoustic transducer
JP4889127B2 (ja) 埋め込み型医療装置のための広帯域音響センサ
US7580750B2 (en) Implantable medical device with integrated acoustic transducer
US8626295B2 (en) Ultrasonic transducer for bi-directional wireless communication
US20050070962A1 (en) Methods and systems for treating heart failure with vibrational energy
US8825161B1 (en) Acoustic transducer for an implantable medical device
KR20190100766A (ko) 체내 이식형 의료기기
WO2004112887A2 (fr) Procedes et systemes pour le traitement de l'insuffisance cardiaque avec l'energie vibratoire
KR20190100765A (ko) 체내 이식형 의료기기

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090107

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

17Q First examination report despatched

Effective date: 20090529

DAX Request for extension of the european patent (deleted)
18D Application deemed to be withdrawn

Effective date: 20150202

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

R18D Application deemed to be withdrawn (corrected)

Effective date: 20150203